Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection.

Lo JC, Kazemi MR, Hsue PY, Martin JN, Deeks SG, Schambelan M, Mulligan K.

Clin Infect Dis. 2005 Nov 1;41(9):1335-40. Epub 2005 Sep 29.

PMID:
16206112
2.
3.

Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy.

John M, Moore CB, James IR, Nolan D, Upton RP, McKinnon EJ, Mallal SA.

AIDS. 2001 Apr 13;15(6):717-23.

PMID:
11371686
4.
6.

Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment.

Vrouenraets SM, Treskes M, Regez RM, Troost N, Smulders YM, Weigel HM, Frissen PH, Brinkman K.

Antivir Ther. 2002 Dec;7(4):239-44.

PMID:
12553477
7.

Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study.

Brown TT, Li X, Cole SR, Kingsley LA, Palella FJ, Riddler SA, Chmiel JS, Visscher BR, Margolick JB, Dobs AS.

AIDS. 2005 Sep 2;19(13):1375-83.

PMID:
16103768
8.

Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens.

Woerle HJ, Mariuz PR, Meyer C, Reichman RC, Popa EM, Dostou JM, Welle SL, Gerich JE.

Diabetes. 2003 Apr;52(4):918-25.

9.

Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level.

Nolan D, Hammond E, James I, McKinnon E, Mallal S.

Antivir Ther. 2003 Dec;8(6):617-26.

PMID:
14760896
10.

Extensive investigations of mitochondrial DNA genome in treated HIV-infected subjects: beyond mitochondrial DNA depletion.

McComsey G, Bai RK, Maa JF, Seekins D, Wong LJ.

J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):181-8.

PMID:
15905734
11.

Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy.

Nolan D, Hammond E, Martin A, Taylor L, Herrmann S, McKinnon E, Metcalf C, Latham B, Mallal S.

AIDS. 2003 Jun 13;17(9):1329-38.

PMID:
12799554
12.

Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy.

Blümer RM, van Vonderen MG, Sutinen J, Hassink E, Ackermans M, van Agtmael MA, Yki-Jarvinen H, Danner SA, Reiss P, Sauerwein HP.

AIDS. 2008 Jan 11;22(2):227-36.

PMID:
18097225
13.

Insulin resistance is affected by increased levels of plasma lactate but not mitochondrial alterations in skeletal muscle in NRTI-exposed HIV-infected patients.

Maagaard A, Holberg-Petersen M, Torjesen PA, Bruun JN, Kvale D.

HIV Clin Trials. 2007 Sep-Oct;8(5):345-53.

PMID:
17956836
14.

Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.

Jones R, Sawleshwarkar S, Michailidis C, Jackson A, Mandalia S, Stebbing J, Bower M, Nelson M, Gazzard BG, Moyle GJ.

HIV Med. 2005 Nov;6(6):396-402.

15.

Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome.

Tozzi V, Zaccarelli M, Bonfigli S, Lorenzini P, Liuzzi G, Trotta MP, Forbici F, Gori C, Bertoli A, Bellagamba R, Narciso P, Perno CF, Antinori A; Collaborative Group for Clinical Use of HIV Genotype Resistance Test..

Antivir Ther. 2006;11(5):553-60.

PMID:
16964822
16.

Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).

Negredo E, Miró O, Rodríguez-Santiago B, Garrabou G, Estany C, Masabeu A, Force L, Barrufet P, Cucurull J, Domingo P, Alonso-Villaverde C, Bonjoch A, Morén C, Pérez-Alvarez N, Clotet B; MULTINEKA Study Group..

Clin Infect Dis. 2009 Sep 15;49(6):892-900. doi: 10.1086/605440.

PMID:
19663689
17.

Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients.

Maagaard A, Holberg-Petersen M, Kvittingen EA, Sandvik L, Bruun JN.

HIV Med. 2006 Jan;7(1):53-8.

18.

Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.

Hadigan C, Corcoran C, Stanley T, Piecuch S, Klibanski A, Grinspoon S.

J Clin Endocrinol Metab. 2000 Jan;85(1):35-41.

PMID:
10634360
19.

Glucose production, oxidation and disposal correlate with plasma lactate levels in HIV-infected patients on HAART.

Haugaard SB, Andersen O, Madsbad S, Iversen J, Dela F.

J Infect. 2007 Jan;54(1):89-97. Epub 2006 Feb 17.

PMID:
16487595
20.

[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].

Oette M, Kaiser R, Däumer M, Fätkenheuer G, Rockstroh JK, Knechten H, Mitrenga D, Beerenwinkel N, Sagir A, Pfister H, Häussinger D.

Dtsch Med Wochenschr. 2007 May 4;132(18):977-82. German.

PMID:
17457780

Supplemental Content

Support Center